Guess which ASX healthcare share is rocketing 67% on a US hospital deal

Here are the details of the company's new hospital contract.

| More on:
A person with a round-mouthed expression clutches a device screen and looks shocked and surprised.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • This healthcare share is soaring 67% today
  • The company has signed its maiden US hospital Software as a Service contract 
  • The healthcare sector is up 1.03% in late trading

This ASX healthcare share is rocketing ahead on the market today.

The 4DMedical Ltd (ASX: 4DX) share price is up 66.7% on yesterday's closing price, currently trading at an intraday high of 52.5 cents. It closed trading yesterday at 31.5 cents a share.

For perspective, the S&P/ASX 200 Healthcare Index (ASX: XHJ) is up 1.03% in late afternoon trade.

Let's take a look at why this ASX healthcare share is booming today.

New five year contract

Investors appear to be buying up 4DMedical shares on the back of news it has signed its "first US hospital Software as a Service (SaaS) contract".

The company has signed a five-year contract with the University of Miami to deliver X-ray velocimetry lung ventilation analysis software ventilation reports.

Under the contract, 4DMedical will provide XV technology to the university to process patient data.

The deal represents a "significant milestone" for the company's commercialisation strategy in the United States.

Commenting on the news, 4DMedical and founder Andreas Fouras said:

Today's announcement of our first US SaaS contract reflects the attainment of a key milestone in the company's commercialisation journey.

Furthermore, the fact this milestone was completed with our clinical trial partners at the University of Miami, who have developed such an extensive understanding of XV Technology, is especially satisfying.

Share price snapshot

Even with today's boost, the 4DMedical share price has fallen 37% in the last year.

This ASX healthcare share has a market capitalisation of $141 million based on the current share price.

Motley Fool contributor Monica O'Shea has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

Shot of a senior scientist looking stressed out while working in a lab.
Healthcare Shares

After soaring 40% in 2 weeks, this ASX All Ords healthcare stock has been downgraded

Here’s what analysts at Macquarie rate the stock as now.

Read more »

A little boy, soon to be a brother, kisses and holds his mum's pregnant tummy.
Healthcare Shares

Own NIB shares? Here are the key dates for 2026

NIB has released its corporate calendar, including dividend dates, for 2026.

Read more »

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused
Healthcare Shares

ASX healthcare stock debuts at a massive discount to its initial public offer price

Saluda Medical shares have had a difficult start to public life, trading well below the initial public offer price.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Healthcare Shares

Why CSL shares now look 'massively oversold'

A leading investment expert says ASX investors have a rare chance to buy CSL shares at a discount.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Which junior biotech's shares are flying on positive trial news?

This company's shares have surged higher after positive clinical trial results for its stroke treatment drug.

Read more »

Excited elderly woman on a swing.
Healthcare Shares

Guess which ASX 300 healthcare share is lifting off on $25 million news

The ASX 300 healthcare share is grabbing investor interest on Thursday. Let’s see why.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Doomed takeover bid for Mayne Pharma to come to an end

The Mayne Pharma takeover saga appears to be finally drawing to an end, with shareholders bearing the pain of the…

Read more »